Prelude Therapeutics Inc
PRLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001678660
No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Prelude Therapeutics Inc changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 58 | 61 | +3 |
| Shares | 34.2M | 33.9M | −294.6K (−0.9%) |
| Value | $162.1M | $129.2M | −$32.9M (−20.3%) |
New holders (10)
Institutions that held Prelude Therapeutics Inc at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Y-Intercept (Hong Kong) Ltd | 18,839 | $71.8K | 0.00% |
| Jacobs Levy Equity Management, Inc | 17,761 | $67.7K | 0.00% |
| Deutsche Bank AG | 14,618 | $55.7K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 8,135 | $31.0K | 0.00% |
| Corebridge Financial, Inc. | 7,092 | $27.0K | 0.00% |
| Qube Research & Technologies Ltd | 3,126 | $11.9K | 0.00% |
| Nisa Investment Advisors, LLC | 2,100 | $8.00K | 0.00% |
| Russell Investments Group, Ltd. | 1,481 | $5.64K | 0.00% |
| The PNC Financial Services Group, Inc. | 64 | $244 | 0.00% |
| SRS Capital Advisors, Inc. | 19 | $73 | 0.00% |
Sold out (7)
Institutions that held Prelude Therapeutics Inc at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Millennium Management LLC | 101,850 | $482.8K |
| Cerity Partners LLC | 32,500 | $154.1K |
| Pale Fire Capital SE | 31,481 | $149.2K |
| Zacks Investment Management | 18,457 | $87.5K |
| Amundi | 15,130 | $52.0K |
| American International Group, Inc. | 7,333 | $34.8K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 1 | $4 |